Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Filings indexed 1,205 across all filing types
Latest filing 2019-08-10 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Lyka Labs Ltd has informed BSE about Outcome of Board Meeting held on August 09, 2019.
Regulatory Filings
2019-08-10 English
Financial Result Updates
Regulatory Filings
2019-08-09 English
Outcome of Board Meeting
Regulatory Filings
2019-08-09 English
With reference to the captioned subject and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of meeting ....
Regulatory Filings
2019-08-09 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 90% confidence The document text is extremely short (291 characters) and contains only address and stock exchange listing information without any substantive content, financial data, or report details. It does not contain any report, announcement, or detailed information. Given the lack of content and the nature of the text, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other categories.
2019-08-03 English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve This is to inform you that, pursuant ....
Regulatory Filings
2019-08-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.